CLINICAL_TRIALS
trial_result
· 2022-08-01
Clinical Trial Update: Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria [Phase 2]
Summary
Phase 2 study of TMX-049 in type 2 diabetes with albuminuria has completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teijin America, Inc. | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-08-01